BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17357056)

  • 1. Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency.
    Assogba BD; Leavell S; Porter K; Burkhard MJ
    J Infect Dis; 2007 Apr; 195(8):1184-8. PubMed ID: 17357056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG from acutely infected cats blocks mucosal feline immunodeficiency virus infection.
    Burkhard MJ; Hoover EA
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):87-95. PubMed ID: 15910995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.
    Paillot R; Richard S; Bloas F; Piras F; Poulet H; Brunet S; Andreoni C; Juillard V
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):1-14. PubMed ID: 15910988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell subpopulations mediating inhibition of feline immunodeficiency virus replication in mucosally infected cats.
    Shimojima M; Nishimura Y; Miyazawa T; Tohya Y; Akashi H
    Microbes Infect; 2004 Mar; 6(3):265-71. PubMed ID: 15026013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
    Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infection.
    Folkl A; Wen X; Kuczynski E; Clark ME; Bienzle D
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):107-14. PubMed ID: 19931185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.
    Howard KE; Reckling SK; Egan EA; Dean GA
    Retrovirology; 2010 Jan; 7():2. PubMed ID: 20085648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.
    Richards JR
    Biologicals; 2005 Dec; 33(4):215-7. PubMed ID: 16257536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIV in cats--a useful model of HIV in people?
    Bienzle D
    Vet Immunol Immunopathol; 2014 Jun; 159(3-4):171-9. PubMed ID: 24636302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent detection of papillomavirus DNA in clinically normal skin of cats infected and noninfected with feline immunodeficiency virus.
    Munday JS; Witham AI
    Vet Dermatol; 2010 Jun; 21(3):307-10. PubMed ID: 20042039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
    Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior virus exposure alters the long-term landscape of viral replication during feline lentiviral infection.
    Zheng X; Carver S; Troyer RM; Terwee JA; VandeWoude S
    Viruses; 2011 Oct; 3(10):1891-908. PubMed ID: 22069521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses.
    VandeWoude S; Hageman CL; Hoover EA
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):20-31. PubMed ID: 14501789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the plasma globulin level, CD21(-) B-cell counts and FOXP3 mRNA expression level in CD4(+) T-cells for different clinical stages of feline immunodeficiency virus infected cats.
    Takano T; Hosoya S; Shibao A; Nagasaki B; Yoshioka H; Satoh R; Hohdatsu T
    Res Vet Sci; 2012 Feb; 92(1):157-61. PubMed ID: 21074227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pathogenesis of transmucosal feline immunodeficiency virus infection.
    Obert LA; Hoover EA
    J Virol; 2002 Jun; 76(12):6311-22. PubMed ID: 12021364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation.
    Joshi A; Vahlenkamp TW; Garg H; Tompkins WA; Tompkins MB
    Virology; 2004 Apr; 321(2):307-22. PubMed ID: 15051390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of feline immunodeficiency virus and feline leukemia virus infections in random-source cats.
    Glennon PJ; Cockburn T; Stark DM
    Lab Anim Sci; 1991 Dec; 41(6):545-7. PubMed ID: 1667194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral latency in peripheral CD4+ T cells isolated from feline immunodeficiency virus-infected cats during the asymptomatic phase is not associated with hypermethylation of the proviral promoter.
    Murphy B; Hillman C; Mok M; Vapniarsky N
    Virus Res; 2012 Oct; 169(1):117-26. PubMed ID: 22846918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.